Figure 1.
Establishing a stable CRISPR/Cas13 system based on K562 cell line. (a) CRISPR/Cas13 can be used to knockdown mRNA and vlincRNAs in K562. Relative expression level (Y-axis) of the corresponding transcripts in cells co-transfected with plasmids expressing Cas13 and the indicated target gRNA vs those co-transfected with Cas13 and the control Gluc gRNA. (b) Inducible stable Cas13 expression in TRE-LwCas13a-K562 cells. Expression fold change (Y-axis) in response to +Dox treatments compared to the −Dox control. Error bars indicate the SE of three technical repeats.